What offer to accept to break into distressed PE?

Hey everyone,

Been lucky enough to end up with 2 offers. Both are absolutely amazing, but the thing is, down the line sometime, I'd love to break into distressed PE, and I think it would be a good idea to accept the offer that gives me the most straightforward shot at doing this. Debated on posting this in the consulting forum, but thought this forum would give me the best shot.

One offer is for growth PE at a UMM PE firm. The other is RX consulting at a Big 3 (FTI / Alix / A&M). I feel like both have their respective strengths and weaknesses, and I'd love for someone to break the options down. 

Appreciate any insights.

12 Comments
 
Most Helpful

Tbh, two really great offers. I can give you my 2 cents on this, having interacted with RX consultants  / consulting firms quite a lot. 

Growth PE at a UMM firm offers a great foundation if you’re looking for broader investing exposure. You’ll build strong modeling chops, get live deal reps, and gain real ownership of portfolio work over time. The brand name helps too, especially if you ever want to lateral or go the MBA-to-distressed route later. The downside? Growth PE is fundamentally different from distressed. You’re underwriting upside and chasing scalability, not fixing broken capital structures or dealing with creditors. So if you stay in that lane too long, it can be harder to credibly pivot into a distressed seat without a compelling story or additional experience (e.g., MBA, credit fund internship, etc.).

RX consulting at a Big 3 (FTI / Alix / A&M) is more niche but highly relevant if your end goal is distressed PE. You’ll be embedded with troubled companies, learning operational triage, liquidity forecasting, Chapter 11 prep, creditor dynamics—basically the language and flow of distressed investing. Distressed PE and special sits funds based on what I've seen actively pull from these benches because the experience is immediately translatable. On top of that, if you're at a shop with strong deal advisory (A&M) or creditor-side mandates (FTI), you’ll start building a name in the right circles early. The trade-off is that it's not traditional investing, and the exit path is narrower if you end up wanting to pivot away from distressed later. Also, comp and lifestyle can be a bit less predictable depending on client load and court timelines. I will say that the hours are absolutely horrible at times, so there's that. 

That's basically the works of the two, and if I were you I'd consider a couple things first:

  • Certainty of your goal: If you’re 90% sure distressed PE is your thing, RX is the more direct launchpad. If you're still feeling out investing more broadly, UMM PE gives you optionality.
  • Exit flexibility: UMM PE is more generalist-friendly if you ever want to pivot into other funds or industries.
  • Brand + prestige: Both routes have strong reputations, but UMM PE will carry more weight on paper to a general audience. RX is more specialized, but within the distressed world, it's extremely well respected.
  • Network: Some RX firms have better pipelines into distressed PE than others. Alix and A&M have strong debtor-side reps. FTI is more creditor side, and more diversified—great brand, but check the specific team.
  • Learning curve: RX will be intense — hours can be brutal (110+), especially in active turnarounds or bankruptcies — but you'll build a super-technical, high-responsibility skill set fast. Growth PE will also be tough, but more deal-paced vs. crisis-paced.
  • Personal interest: If you rlly enjoy distressed situations — messy balance sheets, negotiations, operational fixes, drama — you’ll probs find RX work a lot more intellectually stimulating and relevant.

End of day, there's really no "wrong" choice here. It's possible with either. Hope that helps.

 

Ya know...just bc you don't agree with a viewpoint doesn't mean it's AI lol. I honestly don't see any lies told, it matches up with the anecdotes I've heard. Growth and distressed PE are two different things.

 

It reads to me like someone fed their (possibly well-informed) bullet points into AI and had it reformat to paragraphs with punchy phrasing, then added back in some "human-sounding" stuff: "I will say," "rlly," "probs," etc. The giveaways that it's AI are:

1) Short questions to transition from positive to negative, rather than just saying "however" ("The downside?").

2) Excessive use of em-dash ("--") in the bullet points. I don't think you can even type this directly into WSO; when I try to do it I have to use two short dashes instead.

 

I don't know why you would take the consulting offer here? You rarely ever see Rx consultants in top tier distressed/SS pe funds - they hire mainly from Rx banking, m&a banking or other corp PE funds. Growth PE at UMM gives you excellent resume pedigree and investing experience early on and ability to pivot to regular PE and often perhaps SS as well. I wouldn't make it hard for yourself just because you're interested in distressed, you may change your mind when you start working

 

Agreed, and the original response mentioned that too...you might change your mind so don't set anything in concrete yet. However, if you reeally  want distressed PE, just know that RX consulting doesn't directly give you much in the way of pure investing experience. Consultants primarily fix, not invest. You've gotta actively try to get staffed on deals that do give you that experience. Also, it’s a bit of a niche path. RX guys, especially those from firms like Alix or FTI, are very well-positioned in specific parts of the distressed investing ecosystem. The problem, however, is that a lot of the key decision-makers in distressed funds (especially at top-tier shops) are former bankers or investors themselves, so they may see an RX consultant's experience as a bit tangential. That said, you can transition into distressed PE later on, especially if you can effectively bridge the gap by working on relevant deals, or spending some time in distressed credit (which imo is very achievable from RX consulting).

If you take the UMM PE offer though, you'll get the investor experience, even if it's on the growth side of things. 

All in, I would tend to agree with the guy who wrote the really detailed writeup above, RX consulting is the more direct launchpad, but it doesn't mean it's easy. I've seen / heard many connections in RX making the jump, so speaking with a bit of anecdotal evidence. 

 

Distinctio et explicabo tempore ab quod et. Rerum illo nihil aspernatur dolorem aut voluptate. Architecto ratione impedit officiis neque.

Career Advancement Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.8%
  • JPMorgan 01 98.2%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 01 98.8%
  • Evercore 01 98.2%
  • BMO Capital Markets 12 97.6%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Evercore No 98.8%
  • Morgan Stanley 05 98.2%
  • JPMorgan No 97.7%
  • BMO Capital Markets 12 97.1%

Total Avg Compensation

June 2026 Investment Banking

  • Vice President (14) $434
  • Associates (43) $259
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (75) $151
  • Intern/Summer Analyst (68) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
kanon's picture
kanon
99.0
3
Secyh62's picture
Secyh62
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
DrApeman's picture
DrApeman
98.9
6
CompBanker's picture
CompBanker
98.9
7
dosk17's picture
dosk17
98.9
8
Betsy Massar's picture
Betsy Massar
98.9
9
GameTheory's picture
GameTheory
98.9
10
numi's picture
numi
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”